Currently we operate in emerging markets with our distribution partners and in house brands.
We are open for Out Licensing / Co-development / other models of collaboration, as we expand our footprints to highly regulated markets.
We at Sanzyme are fully aware and prepared of dynamic regulatory landscape in the segment of Biologics/Biosimilars.
Armed with EU GMP & PIC/s for our Finished Formulations, we offer our e-CTD to cater to global regulatory requirements.
Navneet Battu (Vice President – International Business) (firstname.lastname@example.org)
Upendra Dwivedi (email@example.com) and Navneet Battu (Vice President – International Business) (firstname.lastname@example.org)
Since 1969, when we entered into a Joint Venture with Sankyo (now Daiichi-Sankyo) to make gonadotropins to export to Japan, we’ve been at the forefront of biological hormones, and today we have the necessary technological foundation to do path breaking work.